Formerly dba EPET, LLC, in 2003 the firm became NovaScan, LLC. The exclusive licensee of patents held by WiSys, a division of the Wisconsin Alumni Research Foundation (WARF), the firm is working on development of an oncology diagnostic platform designed to provide highly accurate, instantaneous detection of cancer without capital equipment. With a primarily focus on breast cancer detection, NovaScan, LLC is developing technology that electrically images objects - measuring the electrical properties of materials. NovaScan has developed a real-time device to scan tissue to determine if it is cancerous with a high degree of sensitivity and of specificity. The firm also has developed an in-vivo (FastPath residual cancer probe) and ex-vivo (Electrical Mammogram) device to detect breast cancer. FastPath Probe: A hand held probe used by surgeons to detect malignant tissue remaining in the surgical cavity during surgery. Electrical Mammogram: Makes use of the NovaScan proprietary electrical scanning technology as an adjunct to traditional x-ray mammograms to produce a color image that depicts anomalies detected in extracted tissue.
